Durham’s Heat Biologics (Nasdaq: HTBX) is in threat of delisting again.
According to a document filed by Heat with the SEC on Thursday, the company has received notification from the Nasdaq Listing Qualifications Department that “for the preceding 30 consecutive business days (Jan. 31, 2017, through March 14, 2017), the company’s common stock did not maintain [the required] minimum closing bid price of $1.00 …”
Heat further stated in its filing that it has until Sept. 11 to regain compliance,…
Durham’s Heat Biologics (Nasdaq: HTBX) is in threat of delisting again.
According to a document filed by Heat with the SEC on Thursday, the company has received notification from the Nasdaq Listing Qualifications Department that “for the preceding 30 consecutive business days (Jan. 31, 2017, through March 14, 2017), the company’s common stock did not maintain [the required] minimum closing bid price of $1.00 …”
Heat further stated in its filing that it has until Sept. 11 to regain compliance,…